RT Journal Article
SR Electronic
A1 Vinall, Phil
T1 Prostate Cancer: What are the Prospects and Guidelines for Screening and Prevention?
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 15
SP 20
OP 20
DO 10.1177/155989771215014
UL http://mdc.sagepub.com/content/12/15/20.abstract
AB Prostate specific antigen (PSA) is an exceptional biomarker for prostate cancer. While there has been a significant decrease in prostate cancer mortality since the introduction of PSA screening, the benefit of screening can be diminished by the loss of quality of life (QoL) stemming from both the diagnosis itself and the adverse effects of treatment. This article quantifies the effects of screening strategies on prostate cancer mortality and QoL.